article thumbnail

How AI will reshape pharma by 2025

Drug Target Review

Looking ahead, 2025 could represent a major turning point for the pharmaceutical sector. In 2025, I think well see breakthroughs that allow us to make significant advances in rare diseases, where the data is small. While current breakthroughs are impressive, Smith anticipates even greater advancements by 2025.

article thumbnail

CDD Vault Update (February #2 2025):  Advanced Macromolecules - Modified Bioconjugates Support in CDD Vault

Collaborative Drug

CDD Update February 2025 #2 New Macromolecule Mode Edit DNA, RNA & Peptides with Bioconjugate Support

RNA 285
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

CDD Vault Update (March #2 2025):  Macromolecule Atomistic Rendering, AI Datasets, Import Inventory Locations, Larger Inventory Boxes, Dark Mode

Collaborative Drug

CDD Update March #2 2025 Full Atom Layout of Macromolecules New Dataset for AI Similarity Searching Import Inventory Locations by Unique Box Names:

249
249
article thumbnail

Drug Discovery Informatics for Big Pharma: Key Webinar Insights

Collaborative Drug

Our recent Q1 2025 scientific webinar brought together industry veterans Dr. Chris Waller and Dr. Dimitris Agrafiotis to discuss the current state and future directions of drug discovery informatics in large pharmaceutical organizations led by CDD's Founder and CEO, Dr.

Drugs 255
article thumbnail

Bridging Innovation & Patient Care: The Growing Role of AI

Speaker: Simran Kaur, Co-founder & CEO at Tattva.Health

📆 May 1st, 2025 at 11:00 AM PST, 2:00 PM EST, 7:00 PM BST Navigating the AI Landscape 🤖 Explore the opportunities and challenges with integrating AI in healthcare and disease prevention. Register today to save your seat!

article thumbnail

5 questions facing emerging biotech in 2025

BioPharma Drive: Drug Pricing

Young drugmakers confront several harsh realities this year, among them a contracting sector and competition from China.

295
295
article thumbnail

10 clinical trials to watch in the first half of 2025

BioPharma Drive: Drug Pricing

Expected readouts in diabetes, cancer and depression headline a series of study results that could help the biotechnology sector regain its footing after a shaky year.